|
|
Office Locations:
|
4225 Executive Square, Suite 600
La Jolla, CA 92037
Phone: 619-289-7428
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Mesa Verde Venture Partners is a life sciences venture capital fund founded in San Diego in 2006. Mesa Verde Venture Partners' charter is to invest in a diversified portfolio of early-stage biotechnology and medical technology companies in the Southwest. Areas of focus include drug discovery/ tools, medical devices and diagnostics, and healthcare information technology. Mesa Verde Venture Partners is the successor fund to IngleWood Ventures of San Diego. Sanderling is the lead investor behind Mesa Verde Venture Partners. The firm's preferred investment size is $250,000 to $1 million initially and up to $1.5 million per company over time. The firm has over 20 years of experience and over 20 life sciences investments.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
